Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability
BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more… Read More
BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more… Read More
Analysis Finds PBMs Pass On Over 99 Percent of Rebates, Used to Keep Premiums… Read More
Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading… Read More
Four More Rx Giants Complete the Sweep, Beat Q2 Earnings Forecasts After… Read More
Brand Name Drug Makers Continue to Surpass Q2 Forecasts After Hiking Prices… Read More
Three More Drug Makers Top Earnings Expectations in Q2 Today three more… Read More
Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices… Read More
America’s seniors and taxpayers received a huge win today when the… Read More
Washington, D.C. – The U.S. Senate Special Committee on Aging held its third… Read More
Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on… Read More
Part IV: Big Pharma’s Tax Conundrum The average American spends $1… Read More
Part III: As Prices Rise, So Too Does Ad Spending The average American… Read More